[1] [2] It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists , which work by mimicking the action of the naturally occurring hormone GLP-1
Description: L-Glutathione: It is a tripeptide with gamma peptide linkage between the carboxyl group of the glutamate side chain and it is manufactured in the liver by amino acids Cysteine, Glutamic acid and Glycine
, (Redox Bottleneck) , ,
.
Goss has over 35 years of experience litigating high-stakes cases
As a class of drugs, GLP-1s have been shown to result in weight loss.[2] Common side effects of GLP-1s include nausea, vomiting, diarrhea, constipation, injection site reactions, headache, hypoglycemia, dyspepsia, fatigue, dizziness, abdominal pain, and gastroenteritis.[1-4] All GLP-1s carry a boxed warning for the risk of thyroid c-cell tumors and a contraindication for a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
